Melbourne scientists have uncovered new research that provides hope to tackle Dementia with scans for iron levels in the brain that could identify people most at risk of Alzheimer’s.
Scientists have found that patients with high levels of brain plague but low levels of iron have a much higher cognitive performance over a period as much as six years compared with those with high iron levels who progress considerably faster to disease in terms of memory formation.
A drug that is already on the market, an iron chelator drug, is giving hope to patients as it is reducing the levels of iron in the brain for those suffering with Parkinson ís disease. The team of specialists are now looking at testing whether a dose taken twice a day over the space of a year will slow the progression of Alzheimer’s disease.
Plans to include a brain scan in the 60 year old health check and then following with a PET scan with any brain plaque diagnosis could be the key to tackling this disease before any symptoms appear with the added help of medication.
With more and more Australians living with Dementia every year, any hope is good hope.